Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$24.47
$0.271.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.40% | -6.10% | 6.54% | -12.11% | 19.38% |
| Total Depreciation and Amortization | 3.70% | 1.60% | 2.04% | 1.30% | 1.26% |
| Total Amortization of Deferred Charges | 5.25% | -2.69% | -69.46% | 14.47% | -26.95% |
| Total Other Non-Cash Items | 166.95% | -234.71% | 96.55% | 80.78% | 245.49% |
| Change in Net Operating Assets | -94.58% | -17.24% | -184.85% | 218.86% | 72.84% |
| Cash from Operations | 20.86% | -51.60% | -13.24% | 24.99% | 131.69% |
| Capital Expenditure | 13.81% | 10.02% | -128.21% | 31.26% | 6.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.02% | -11.90% | -131.92% | 171.08% | 125.67% |
| Cash from Investing | 129.38% | -3.16% | 50.52% | -558.77% | 114.79% |
| Total Debt Issued | -66.27% | -48.80% | 38,132.00% | -100.61% | -- |
| Total Debt Repaid | 66.96% | -180.49% | 99.49% | -8,072.45% | 99.80% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 59.38% | -21.84% | -1,081.36% | 84.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,018.18% | 103.75% | -58,800.00% | 100.40% | 48.68% |
| Cash from Financing | 57.14% | -48.33% | -112.92% | 21.08% | 71.16% |
| Foreign Exchange rate Adjustments | 1,172.73% | 82.54% | -231.58% | 80.41% | 59.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 176.96% | -1,722.23% | 121.66% | -120.28% | 144.94% |